Dein Suchergebnis zum Thema: per

A sweet defence against lethal bacteria

https://www.mpg.de/4328759/sugar_defence_bacteria

There is now a promising vaccine candidate for combating the pathogen which causes one of the most common and dangerous hospital infections. An international team of scientists from the Max Planck Institute of Colloids and Interfaces in Potsdam has developed a vaccine based on a carbohydrate against the Clostridium difficile bacterium, which is known to cause serious gastrointestinal diseases mainly in hospitals. The sugar-based vaccine elicited a specific and effective immune response in mice. Moreover, the scientists have also discovered strong indications that the substance can stimulate the human immune system to form antibodies against the bacterium.
Whereas no more than four per cent of healthy humans have C. difficile in their gastrointestinal

Editoren-Team für neues Open Access Journal steht

https://www.mpg.de/4641339/elife

Die Max-Planck-Gesellschaft unterstützt zusammen mit dem Howard Hughes Medical Institute (USA) und dem Wellcome Trust (UK) die Herausgabe eines neuen Open Access-Fachjournals im Bereich der Biomedizin und Life Sciences. Bereits im Juni 2011 hatten die drei Organisationen eine entsprechende Vereinbarung (Head of Terms) unterzeichnet.
Wissenschaftseinrichtungen haben sich dem Ziel angeschlossen, die große Mehrheit der heute per